Tetranectin levels in patients with acute myocardial infarction and their alterations during thrombolytic treatment.
about
Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformityProtein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative.Aberrant tetranectin expression in human breast carcinomas as a predictor of survivalTetranectin as a Potential Biomarker for Stable Coronary Artery Disease.Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome.Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link.
P2860
Tetranectin levels in patients with acute myocardial infarction and their alterations during thrombolytic treatment.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Tetranectin levels in patients ...... during thrombolytic treatment.
@en
Tetranectin levels in patients ...... during thrombolytic treatment.
@nl
type
label
Tetranectin levels in patients ...... during thrombolytic treatment.
@en
Tetranectin levels in patients ...... during thrombolytic treatment.
@nl
prefLabel
Tetranectin levels in patients ...... during thrombolytic treatment.
@en
Tetranectin levels in patients ...... during thrombolytic treatment.
@nl
P2093
P1476
Tetranectin levels in patients ...... during thrombolytic treatment.
@en
P2093
C Stefanadis
E F Kamper
J Stavridis
L Kopeikina
P Toutouzas
P304
P356
10.1177/000456329803500309
P478
35 ( Pt 3)
P577
1998-05-01T00:00:00Z